share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer COWHEY THOMAS F.

SEC announcement ·  Apr 3 17:00
Summary by Moomoo AI
On April 1, 2024, CVS Health EVP and CFO Thomas F. Cowhey completed a stock transaction involving the company's shares. Cowhey sold 1,719 shares of common stock at a price of $79.56 per share, resulting in a total transaction value of $136,763.64. This sale was executed under the transaction code 'F', typically associated with the payment of exercise price or tax liability by delivering or withholding securities. Prior to this sale, Cowhey acquired 15,082 shares of restricted common stock at no cost, which is often related to grants, awards, or other acquisitions as part of compensation. Following these transactions, Cowhey's direct holdings in CVS Health common stock amounted to 47,995 shares.
On April 1, 2024, CVS Health EVP and CFO Thomas F. Cowhey completed a stock transaction involving the company's shares. Cowhey sold 1,719 shares of common stock at a price of $79.56 per share, resulting in a total transaction value of $136,763.64. This sale was executed under the transaction code 'F', typically associated with the payment of exercise price or tax liability by delivering or withholding securities. Prior to this sale, Cowhey acquired 15,082 shares of restricted common stock at no cost, which is often related to grants, awards, or other acquisitions as part of compensation. Following these transactions, Cowhey's direct holdings in CVS Health common stock amounted to 47,995 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more